Will Current Price Volatility Hamper GSK Plc ADR (GSK) Future Potential?
GSK Plc ADR (NYSE:GSK) has a beta value of 0.67 and has seen 1.23 million shares traded in the recent trading session. The company, currently
GSK Plc ADR (NYSE:GSK) has a beta value of 0.67 and has seen 1.23 million shares traded in the recent trading session. The company, currently
During the recent session, GSK Plc ADR (NYSE:GSK)’s traded shares were 2.63 million, with the beta value of the company hitting 0.66. At the last
In today’s recent session, 3.52 million shares of the GSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.66. Most recently the company’s
GSK Plc ADR (NYSE:GSK)’s traded shares stood at 3.34 million during the last session, with the company’s beta value hitting 0.66. At the close of
GSK Plc ADR (NYSE:GSK) has a beta value of 0.66 and has seen 0.86 million shares traded in the recent trading session. The company, currently
During the last session, GSK Plc ADR (NYSE:GSK)’s traded shares were 19.7 million, with the beta value of the company hitting 0.66. At the end
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.